Stock listing

NASDAQ:UNCY Unicycive Therapeutics, Inc. Stock

Home listing (NASDAQ) of Unicycive Therapeutics, Inc.

Follow Unicycive Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:UNCY

$3.35 USD -0.22 (-6.2%)

Close on Nov 20, 2026

Past year -36.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$3.35 – $3.62 USDNov 20, 2026
Volume
1.36M sharesNov 20, 2026
Market cap
$97.77M USDAt the close on Nov 20, 2026 · price × 29.18M shares outstanding
52-week range
$3.33 – $8.74 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$4.05M USDMedian day 891,630 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Unicycive Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:UNCY · Home$3.35 USD-0.22 (-6.2%)1,355,565$3.48$3.615$3.345$3.57Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:UNCY · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.35-0.22-6.2%$3.48$3.615$3.3451,355,565
$3.57-0.13-3.5%$3.70$3.83$3.5551,387,681
$3.700.000.0%$3.69$3.77$3.591,107,391
$3.70+0.15+4.2%$3.58$3.78$3.551,237,545
$3.55-0.09-2.5%$3.63$3.688$3.52679,926
$3.64-0.14-3.7%$3.70$3.71$3.56782,192
$3.78+0.12+3.3%$3.68$3.855$3.639631,084
$3.66-0.04-1.1%$3.62$3.78$3.60641,316
$3.70+0.15+4.2%$3.55$3.76$3.50842,147
$3.55+0.07+2.0%$3.46$3.59$3.454602,365
$3.48-0.27-7.2%$3.69$3.72$3.371,466,553
$3.75+0.16+4.5%$3.67$3.79$3.63529,867
$3.59+0.10+2.9%$3.50$3.64$3.48940,807
$3.49-0.25-6.7%$3.60$3.61$3.332,234,597
$3.74-0.07-1.8%$3.77$3.93$3.623977,989
$3.81+0.05+1.3%$3.815$3.87$3.74891,630
$3.76+0.15+4.2%$3.60$3.77$3.581,129,015
$3.61+0.03+0.8%$3.60$3.69$3.481,340,066
$3.58-0.31-8.0%$3.90$3.90$3.5341,316,093
$3.89-0.05-1.3%$3.95$4.017$3.7051,212,400
$3.94+0.07+1.8%$3.87$4.00$3.83742,800
$3.87+0.07+1.8%$4.08$4.18$3.8251,437,900
$3.80+0.29+8.3%$3.53$3.87$3.521,207,900
$3.51+0.15+4.5%$3.37$3.64$3.3551,126,600
$3.36-0.23-6.4%$3.58$3.595$3.351,102,300
$3.59-0.11-3.0%$3.70$3.708$3.56893,000
$3.70-0.03-0.8%$3.73$3.81$3.591,208,800
$3.73-0.32-7.9%$3.99$4.02$3.671,836,600
$4.05-0.06-1.5%$4.10$4.11$3.99912,800
$4.11+0.04+1.0%$4.07$4.20$4.05551,400
$4.07-0.11-2.6%$4.16$4.199$4.031,176,100
$4.18-0.05-1.2%$4.15$4.22$4.08590,700
$4.23+0.04+1.0%$4.20$4.294$4.15785,400
$4.19-0.03-0.7%$4.22$4.275$4.12681,400
$4.22-0.33-7.3%$4.62$4.62$4.091,510,100
$4.55-0.145-3.1%$4.71$4.76$4.5451,068,800
$4.695+0.145+3.2%$4.61$4.81$4.574862,700
$4.55-0.09-1.9%$4.66$4.70$4.282,306,600
$4.64-0.055-1.2%$4.66$4.68$4.53601,500
$4.695-0.115-2.4%$4.83$4.85$4.66494,100
$4.810.000.0%$4.81$4.855$4.62660,300
$4.81-0.15-3.0%$4.94$4.96$4.73771,800
$4.96+0.19+4.0%$4.80$4.97$4.76587,700
$4.77-0.03-0.6%$4.85$4.85$4.745448,400
$4.80+0.03+0.6%$4.80$4.85$4.761,108,400
$4.77-0.01-0.2%$4.86$4.88$4.71647,200
$4.78+0.07+1.5%$4.85$4.90$4.691904,000
$4.71-0.44-8.5%$5.15$5.15$4.711,691,100
$5.15-0.14-2.6%$5.27$5.35$5.13671,000
$5.29-0.02-0.4%$5.34$5.40$5.221,116,700
$5.31+0.19+3.7%$5.07$5.62$5.041,241,800
$5.12+0.09+1.8%$5.03$5.14$5.01907,000
$5.03-0.13-2.5%$5.13$5.22$5.025817,200
$5.16-0.14-2.6%$5.24$5.24$5.12492,900
$5.30+0.11+2.1%$5.20$5.34$5.08836,100
$5.19+0.14+2.8%$5.10$5.22$5.06760,500
$5.05-0.15-2.9%$5.13$5.21$5.04671,300
$5.20-0.065-1.2%$5.27$5.27$5.13574,300
$5.265-0.235-4.3%$5.50$5.50$5.26609,200
$5.50+0.07+1.3%$5.43$5.515$5.42366,200
$5.43-0.04-0.7%$5.46$5.55$5.35906,200
$5.47+0.13+2.4%$5.40$5.52$5.32417,050
$5.34-0.29-5.2%$5.64$5.64$5.26742,955
$5.63+0.18+3.3%$5.51$5.77$5.501,013,100
$5.45-0.13-2.3%$5.60$5.68$5.41643,200

Splits

1 split · NASDAQ:UNCY · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
NASDAQ:UNCY
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Unicycive Therapeutics, Inc. news

Unicycive Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 110 in all · newest Nov 16, 2026 · oldest 2021
Decks
4 decks · latest November 2026

Where Unicycive Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:UNCY · Home listing · This pageNASDAQUnited StatesUSD
BOATS:UNCYBOATSUnited StatesUSD

Valuation

Price/book 1.9× against a median of 2.7×: 3rd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$39.32M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
1.9×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.09

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Unicycive Therapeutics, Inc. · NASDAQ:UNCYUS$97.77MUS$39.32Mn/an/an/a1.9×n/a0.0×1.09
BRIM Biotechnology, Inc. · TWSE:6885US$100.3MUS$70.73Mn/a220×n/a2.1×n/a0.0×n/a
Minerva Neurosciences, Inc · NASDAQ:NERVUS$99.67MUS$22.73Mn/an/an/an/an/an/a1.68
NovaBridge Biosciences · NASDAQ:NBPUS$96.28MUS$68.30Mn/an/an/a3.2×n/a0.0×1.37
Wuhan YZY Biopharma Co., Ltd. Class H · HKEX:2496US$96.18MUS$105.6Mn/a7.8×n/an/a−53.2%n/an/a
PDS Biotechnology Corporation · NASDAQ:PDSBUS$95.39MUS$80.15Mn/an/an/a7.1×n/a0.0×2.04
Immunic, Inc. · NASDAQ:IMUXUS$95.37M−US$36.09Mn/an/an/a0.9×n/a0.0×1.51
Allergy Therapeutics plc · LSE:AGYUS$95.34MUS$117.2Mn/a1.6×n/a17.1×−72.9%6.3×n/a
NRX Pharmaceuticals, Inc. · NASDAQ:NRXPUS$95.31MUS$76.46Mn/a17.7×n/an/a−458.5%n/a2.23
Voyager Therapeutics, Inc. · NASDAQ:VYGRUS$95.21M−US$11.60Mn/a−0.5×n/a0.7×−416.3%0.0×1.45
Outlook Therapeutics, Inc. · NASDAQ:OTLKUS$94.94MUS$83.70Mn/an/an/an/an/an/a1.10
Median of the othersUS$95.38MUS$73.59M7.8×2.7×−244.6%0.0×1.51

Forecasts

8 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
26.30 USD · Analysts' mean
EPS, year to Dec 2026
-1.26 · 8 analysts
Revenue, year to Dec 2026
1.28M · 9 analysts

Team and board

Officers

OfficerRole
Shalabh GuptaFounder, President, Chief Executive Officer, and Chairman of the Board

Board

DirectorRole
Shalabh GuptaFounder, President, Chief Executive Officer, and Chairman of the Board
Meredith ManningBoard Member

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026 · Before open+4.2%
Q2 2026Aug 12, 2026 · Before open+7.8%
Q1 2026May 12, 2026+7.0%
Q4 2025Mar 30, 2026 · Before open−4.4%
Q3 2025Nov 12, 2025 · Before open+7.3%
Q2 2025Aug 14, 2025 · Before open+5.0%
Q1 2025May 14, 2025 · Before open−7.9%
Q4 2024Mar 31, 2025−11.1%
Q3 2024Nov 13, 2024 · Before open−1.2%
Q2 2024Aug 14, 2024 · Before open+33.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 13, 2024 · After close0.0%
Q4 2023Mar 28, 2024 · After close+2.2%
Q3 2023Nov 14, 2023 · After close+0.6%
Q2 2023Aug 14, 2023 · After close−7.4%
Q1 2023May 16, 2023 · Before open−4.2%
Q4 2022Mar 31, 2023 · Before open+11.7%
Q3 2022Nov 14, 2022 · Before open−5.6%
Q2 2022Aug 15, 2022 · After close−1.4%
Q1 2022May 12, 2022 · Before open−2.8%
Q4 2021Mar 31, 2022 · Before open−2.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck33 slidesNovember 2026
Investor Presentation (October 2026)Investor deck33 slidesOctober 2026
Technical Presentation (June 2024)Technical29 slidesJun 25, 2024
Corporate Update (December 2022)Corporate update12 slidesDec 28, 2022

Open Decks

IPO

Priced at US$5.00 a unit on Jul 13, 2021.

Price
US$5.00 a unit
Units offered
5,000,000 units
Offering size
US$25 million
Underwriters' option
Up to 750,000 more units
Listing
UNCY on the Nasdaq Capital Market
Underwriter
Roth Capital Partners
Units delivered
On or about Jul 15, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceSep 15, 2020
Filed publiclyMay 21, 2021
Amended 5 timesNewest Jul 12, 2021
Shares registered with an exchangeJul 6, 2021
Declared effective by the SECJul 12, 2021
Final prospectus, with the priceJul 14, 2021

Filings

FilingFiled
424B4 · ProspectusJul 14, 2021
EFFECT · Notice that a registration is effectiveJul 12, 2021
S-1/A · Registration statement, amendedJul 12, 2021
S-1/A · Registration statement, amendedJul 12, 2021
CORRESP · Letter to the SECJul 8, 2021
CORRESP · Letter to the SECJul 8, 2021
CORRESP · Letter to the SECJul 7, 2021
CERT · Exchange's certificate of listingJul 7, 2021
8-A12B · Registration of shares for listing on an exchangeJul 6, 2021
CORRESP · Letter to the SECJul 6, 2021
All 34 filings
FilingFiled
CORRESP · Letter to the SECJul 6, 2021
S-1/A · Registration statement, amendedJun 30, 2021
CORRESP · Letter to the SECJun 23, 2021
CORRESP · Letter to the SECJun 22, 2021
S-1/A · Registration statement, amendedJun 21, 2021
CORRESP · Letter to the SECJun 14, 2021
CORRESP · Letter to the SECJun 14, 2021
CORRESP · Letter to the SECJun 7, 2021
S-1/A · Registration statement, amendedJun 7, 2021
UPLOAD · Letter from the SECJun 3, 2021
CORRESP · Letter to the SECMay 21, 2021
S-1 · Registration statementMay 21, 2021
UPLOAD · Letter from the SECMay 10, 2021
DRS/A · Draft registration statement, amendedApr 29, 2021
DRSLTR · Letter to the SEC with a draftApr 29, 2021
UPLOAD · Letter from the SECMar 17, 2021
DRS/A · Draft registration statement, amendedFeb 18, 2021
DRSLTR · Letter to the SEC with a draftFeb 18, 2021
UPLOAD · Letter from the SECNov 10, 2020
DRS/A · Draft registration statement, amendedNov 2, 2020
DRSLTR · Letter to the SEC with a draftOct 30, 2020
UPLOAD · Letter from the SECOct 9, 2020
DRSLTR · Letter to the SEC with a draftSep 15, 2020
DRS · Draft registration statementSep 15, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Jul 14, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue00675.0K951.0K000
Cost of revenue572.0K428.0K284.0K7.00K1.00K
Gross profit-572.0K-428.0K675.0K951.0K-1.00K
Research and development9.12M20.0M12.9M12.4M6.08M1.01M795.0K344.0K
Selling, general and administrative20.4M12.1M8.55M383.0K245.0K58.0K1.17M608.0K
Operating income-29.5M-32.1M-20.8M-18.1M-8.98M-2.02M-1.96M-952.0K
Depreciation and amortization34.0K22.0K9.00K428.0K468.0K63.0K1.96M952.0K
EBITDA-29.5M-32.1M-20.8M-17.6M-8.51M-1.96M00
Interest expense71.0K71.0K82.0K6.00K628.0K244.0K139.0K0
Income before tax-26.6M-36.7M-30.5M-18.1M-10.0M-2.26M-2.17M-1.12M
Income tax-1.09M116.1K6.00K615.0K244.0K139.0K-952.0K
Net income-26.6M-36.7M-30.5M-18.1M-10.0M-2.26M-2.30M-1.12M
Earnings per share, basic-1.67-5.65-1.28-1.20-0.86-0.27-1.51-0.73
Earnings per share, diluted-1.67-5.65-1.28-1.20-0.86

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents29.2M26.1M9.70M455.0K16.6M015.0K25.0K
Short-term investments12.1M0
Inventory2.19M1.83M
Current assets49.0M30.9M13.4M2.64M18.4M204.0K19.0K29.0K
Property, plant and equipment66.0K75.0K26.0K22.0K28.0K
Total assets49.1M31.7M14.2M2.82M18.7M204.0K19.0K29.0K
Accounts payable383.0K1.06M839.0K892.0K742.0K184.0K322.0K60.0K
Current liabilities18.9M24.1M17.5M3.28M2.10M2.88M903.0K1.24M
Total debt199.0K773.0K811.0K201.0K335.0K2.51M460.0K1.05M
Total liabilities18.9M24.2M18.0M3.28M2.26M2.88M903.0K1.24M
Shareholders' equity30.2M7.43M-3.81M-466.0K16.5M-2.67M-884.0K-1.21M
Shares outstanding22.1M11.4M34.8M15.2M15.0M8.51M1.52M1.52M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-31.3M-28.6M-18.3M-15.7M-5.77M-1.46M-1.18M-775.0K
Capital spending-24.0K-72.0K-12.0K-2.00K-29.0K-29.0K-29.0K-29.0K
Free cash flow-31.3M-28.6M-18.3M-15.7M-5.80M-1.46M-1.18M-775.0K
Cash from investing-12.1M-72.0K-12.0K-2.00K-29.0K-29.0K-29.0K-29.0K
Cash from financing46.5M45.1M27.5M-471.0K22.4M1.44M1.17M800.0K
Dividends paid0-1.09M-900.0K
Change in cash3.06M16.4M9.25M-16.1M16.6M-15.0K-10.0K25.0K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
8-K · Current reportNov 16, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
4 · Change in ownershipOct 29, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 1, 2026Insider tradeSEC
8-K · Current reportSep 29, 2026Management or board changeSEC
8-K · Current reportSep 28, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportAug 12, 2026ResultsSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeJul 30, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
4/A · Change in ownership, amendedJul 28, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 8, 2026Big-stake noticeSEC
8-K · Current reportJul 2, 2026Current reportSEC
144 · Notice of proposed saleJul 1, 2026Other filingsSEC
DEFA14A · Additional proxy materialJun 22, 2026Meeting noticeSEC
8-K · Current reportJun 22, 2026Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveJun 16, 2026Other filingsSEC
4/A · Change in ownership, amendedJun 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJun 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJun 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJun 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJun 15, 2026Insider tradeSEC
4/A · Change in ownership, amendedJun 15, 2026Insider tradeSEC
CORRESP · Letter to the SECJun 11, 2026Other filingsSEC
UPLOAD · Letter from the SECJun 11, 2026Other filingsSEC
8-K · Current reportJun 5, 2026Material contractSEC
S-3 · Registration statementJun 5, 2026Offer documentSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
8-K · Current reportMay 12, 2026ResultsSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
S-8 · Registration statement for employee plansMay 5, 2026Offer documentSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 30, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
8-K · Current reportApr 6, 2026Management or board changeSEC
8-K · Current reportMar 30, 2026ResultsSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJan 23, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
8-K · Current reportNov 14, 2025Current reportSEC
424B5 · ProspectusNov 14, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
8-K · Current reportNov 12, 2025ResultsSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportOct 28, 2025ResultsSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
8-K · Current reportAug 18, 2025Current reportSEC
8-K · Current reportAug 15, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
8-K · Current reportAug 14, 2025ResultsSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
8-K · Current reportJul 8, 2025Current reportSEC
8-K · Current reportJun 30, 2025ResultsSEC
8-K · Current reportJun 20, 2025Current reportSEC
424B5 · ProspectusJun 13, 2025Offer documentSEC
8-K · Current reportJun 10, 2025Current reportSEC
DEFA14A · Additional proxy materialJun 9, 2025Meeting noticeSEC
8-K · Current reportJun 9, 2025Meeting outcomeSEC
DEFA14A · Additional proxy materialMay 21, 2025Meeting noticeSEC
DEFA14A · Additional proxy materialMay 21, 2025Meeting noticeSEC
8-K · Current reportMay 21, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
8-K · Current reportMay 14, 2025ResultsSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialMay 7, 2025Meeting noticeSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 18, 2025Meeting noticeSEC
8-K/A · Current report, amendedApr 14, 2025Material contractSEC
S-8 · Registration statement for employee plansApr 1, 2025Offer documentSEC
8-K · Current reportMar 31, 2025ResultsSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2025Big-stake noticeSEC
8-K · Current reportJan 7, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 20, 2024Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 20, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveNov 21, 2024Other filingsSEC
CORRESP · Letter to the SECNov 18, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveNov 15, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECNov 14, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
S-3 · Registration statementNov 13, 2024Offer documentSEC
SC 13G · Big-stake noticeNov 13, 2024Big-stake noticeSEC
POS AM · Amendment to an effective registrationNov 13, 2024Offer documentSEC
8-K · Current reportNov 13, 2024ResultsSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024Current reportSEC
SC 13G · Big-stake noticeOct 11, 2024Big-stake noticeSEC
4 · Change in ownershipOct 10, 2024Insider tradeSEC
8-K · Current reportSep 24, 2024Current reportSEC
4 · Change in ownershipAug 14, 2024Insider tradeSEC
4 · Change in ownershipAug 14, 2024Insider tradeSEC
4 · Change in ownershipAug 14, 2024Insider tradeSEC
4 · Change in ownershipAug 14, 2024Insider tradeSEC
8-K · Current reportAug 14, 2024ResultsSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
SC 13G · Big-stake noticeJul 18, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveJul 17, 2024Other filingsSEC
424B3 · ProspectusJul 16, 2024Offer documentSEC
8-K · Current reportJul 15, 2024Current reportSEC
8-K · Current reportJul 15, 2024Current reportSEC
CORRESP · Letter to the SECJul 11, 2024Other filingsSEC
UPLOAD · Letter from the SECJul 8, 2024Other filingsSEC
S-3 · Registration statementJul 5, 2024Offer documentSEC
8-K · Current reportJul 2, 2024Material contractSEC
8-K · Current reportJun 26, 2024Current reportSEC
8-K · Current reportJun 25, 2024Current reportSEC
8-K · Current reportJun 20, 2024Meeting outcomeSEC
8-K · Current reportMay 13, 2024ResultsSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
DEFA14A · Additional proxy materialMay 8, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
4 · Change in ownershipApr 17, 2024Insider tradeSEC
PRE 14A · Preliminary proxy statementApr 16, 2024Meeting noticeSEC
8-K · Current reportMar 28, 2024ResultsSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
DMar 20, 2024Other filingsSEC
8-K · Current reportMar 14, 2024Material contractSEC
8-K · Current reportMar 14, 2024Material contractSEC
8-K · Current reportFeb 21, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 2, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJan 22, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansDec 8, 2023Offer documentSEC
8-K · Current reportNov 14, 2023ResultsSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
8-K · Current reportOct 23, 2023Current reportSEC
8-K · Current reportSep 25, 2023Current reportSEC
4 · Change in ownershipSep 7, 2023Insider tradeSEC
4 · Change in ownershipSep 7, 2023Insider tradeSEC
4 · Change in ownershipSep 7, 2023Insider tradeSEC
4 · Change in ownershipSep 7, 2023Insider tradeSEC
3 · Initial statement of ownershipSep 7, 2023Insider tradeSEC
8-K · Current reportSep 6, 2023Management or board changeSEC
8-K · Current reportAug 31, 2023Current reportSEC
4 · Change in ownershipAug 30, 2023Insider tradeSEC
4 · Change in ownershipAug 30, 2023Insider tradeSEC
4 · Change in ownershipAug 30, 2023Insider tradeSEC
4 · Change in ownershipAug 30, 2023Insider tradeSEC
8-K · Current reportAug 14, 2023ResultsSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
EFFECT · Notice that a registration is effectiveAug 4, 2023Other filingsSEC
CORRESP · Letter to the SECAug 1, 2023Other filingsSEC
8-K · Current reportJul 31, 2023Current reportSEC
8-K · Current reportJul 26, 2023Current reportSEC
UPLOAD · Letter from the SECJul 19, 2023Other filingsSEC
SC 13G · Big-stake noticeJul 14, 2023Big-stake noticeSEC
4 · Change in ownershipJul 13, 2023Insider tradeSEC
4 · Change in ownershipJul 13, 2023Insider tradeSEC
4 · Change in ownershipJul 13, 2023Insider tradeSEC
4 · Change in ownershipJul 13, 2023Insider tradeSEC
S-3 · Registration statementJul 12, 2023Offer documentSEC
SC 13G · Big-stake noticeJul 6, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeJul 6, 2023Big-stake noticeSEC
8-K · Current reportJun 29, 2023Current reportSEC
8-K · Current reportJun 26, 2023Meeting outcomeSEC

This page holds 200 of 311 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Unicycive Therapeutics, Inc.’s releases · as of Nov 16, 2026

Common shares
29,184,509
Fully diluted
29,184,509

Fully diluted

LineSharesAs of
Common shares29,184,509Nov 16, 2026

Share count over time

CountShares
Nov 16, 202629,184,509
Sep 30, 202629,110,352

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Vanguard1.5M5.1%US$7.06M+105KNov 13, 2026
BlackRock1.41M4.8%US$6.61M−6,357Nov 13, 2026
Nantahala Capital Management, LLC1.4M4.8%US$6.58M−1.4MNov 13, 2026
Geode Capital595K2.0%US$2.79M+31,043Nov 6, 2026
Millennium497K1.7%US$2.34M+226KNov 16, 2026
State Street480K1.6%US$2.25M+29,434Nov 12, 2026
Logos Global Management LP474K1.6%US$2.22MNo changeNov 19, 2026
Diametric Capital, LP404K1.4%US$1.9M+30,029Nov 16, 2026
Orbimed Advisors LLC387K1.3%US$1.82MNewNov 16, 2026
Eversept Partners, LP336K1.2%US$1.58MNewNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Dauntless Investment Group, LLC323K1.1%US$1.52M+109KNov 16, 2026
Octagon Capital Advisors LP275K0.94%US$1.29M−725KNov 16, 2026
Arrowstreet Capital, Limited Partnership269K0.92%US$1.26MNewNov 13, 2026
Goldman Sachs263K0.90%US$1.23M+117KNov 16, 2026
Jane Street213K0.73%US$1M+202KNov 12, 2026
UBS197K0.68%US$926K+128KNov 10, 2026
Northern Trust192K0.66%US$903K+10,500Nov 16, 2026
Hurricane Capital Advisors LLC165K0.57%US$775KNewNov 16, 2026
Los Angeles Capital Management LLC161K0.55%US$755K+65,777Nov 12, 2026
Marshall Wace, LLP136K0.46%US$637K−412KNov 13, 2026
Susquehanna133K0.46%US$624K−27,209Nov 16, 2026
Dimensional129K0.44%US$605K−14,018Nov 4, 2026
Morgan Stanley124K0.43%US$584K+14,824Nov 13, 2026
Citadel105K0.36%US$494K+44,094Nov 16, 2026
Cantor Fitzgerald, L. P.102K0.35%US$481K+2,410Nov 16, 2026
Simplex Trading, LLC97,3860.33%US$457K+56,964Nov 4, 2026
AQR Capital Management LLC83,2160.29%US$391KNewNov 16, 2026
XTX Topco Ltd75,8200.26%US$356K+65,220Nov 16, 2026
J. Goldman & Co LP69,4520.24%US$326K−258KNov 16, 2026
Wealth Enhancement Advisory Services, LLC64,5040.22%US$263K+44,556Oct 13, 2026
Virtu Financial LLC59,4840.20%US$279K+47,874Nov 17, 2026
Schwab54,8210.19%US$257K−21Nov 16, 2026
BNY53,2670.18%US$250K+460Nov 5, 2026
Seven Fleet Capital Management LP51,7000.18%US$243K−51,700Nov 16, 2026
Quadrature Capital Ltd49,9840.17%US$235KNewNov 13, 2026
Nuveen48,0730.16%US$226K+253Nov 10, 2026
Rhumbline Advisers28,9740.10%US$136K−314Nov 10, 2026
Prelude Capital Management, LLC28,3550.10%US$133K+636Nov 16, 2026
Bank of America27,7560.10%US$130K−3,882Nov 16, 2026
Chicago Partners Investment Group LLC26,9660.09%US$105K+5,556Oct 26, 2026
Squarepoint Ops LLC25,8810.09%US$122KNewNov 9, 2026
AllianceBernstein21,5800.07%US$101KNo changeNov 16, 2026
DWS21,2940.07%US$100K−2,980Nov 6, 2026
T. Rowe Price20,0480.07%US$95,000No changeNov 16, 2026
Group One Trading LLC19,7340.07%US$92,651+17,434Nov 10, 2026
Great Valley Advisor Group, Inc.16,1980.06%US$76,000NewNov 9, 2026
Sei Investments Co14,7610.05%US$69,303No changeNov 10, 2026
Invesco14,0100.05%US$65,777+803Nov 12, 2026
Persistent Asset Partners Ltd13,0500.04%US$61,270−77,115Nov 12, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.11,8540.04%US$55,655+603Nov 16, 2026

This page holds 50 of 92 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund806K2.8%US$3.78M+195KJun 30, 2026
iShares Russell 2000 ETF616K2.1%US$2.89MNewJun 30, 2026
Fidelity Small Cap Index Fund269K0.92%US$1.35MNewJul 31, 2026
Vanguard Extended Market Index Fund240K0.82%US$1.13M+58,277Jun 30, 2026
iShares Russell 2000 Growth ETF202K0.69%US$946KNewJun 30, 2026
Fidelity Extended Market Index Fund84,5540.29%US$624K−2,329May 31, 2026
iShares Micro-Cap ETF81,9760.28%US$384KNewJun 30, 2026
Dimensional U.S. Small Cap ETF67,8270.23%US$340KNo changeJul 31, 2026
Schwab Small-Cap Index Fund54,8420.19%US$275KNewJul 31, 2026
Master Small Cap Index Series45,6750.16%US$214KNewJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Nuveen Small Cap Blend Index Fund33,0590.11%US$166KNewJul 31, 2026
Fidelity Total Market Index Fund26,9750.09%US$199KNo changeMay 31, 2026
EQ/2000 Managed Volatility Portfolio26,5280.09%US$124KNewJun 30, 2026
Fidelity Series Total Market Index Fund24,5770.08%US$181K+2,297May 31, 2026
iShares Russell 2000 Value ETF23,6410.08%US$111KNewJun 30, 2026
Fidelity Small Cap Growth Index Fund20,0320.07%US$93,950NewJun 30, 2026
LVIP State Street Small-Cap Index Fund18,3000.06%US$85,827NewJun 30, 2026
U.S. Micro Cap Portfolio16,3970.06%US$82,149No changeJul 31, 2026
Fidelity Nasdaq Composite Index Fund16,2760.06%US$120K+9,492May 31, 2026
Vanguard Institutional Total Stock Market Index Fund14,4110.05%US$67,588+7,074Jun 30, 2026
Small Cap Index Fund12,7310.04%US$59,708NewJun 30, 2026
Global X Russell 2000 ETF11,6740.04%US$58,487NewJul 31, 2026
Vanguard Balanced Index Fund11,3370.04%US$53,171No changeJun 30, 2026
U.S. Small Cap Portfolio10,8060.04%US$54,138No changeJul 31, 2026
EQ/AB Small Cap Growth Portfolio10,7900.04%US$50,605NewJun 30, 2026
EQ/Small Company Index Portfolio10,7900.04%US$50,605NewJun 30, 2026
MetLife Russell 2000 Index Portfolio8,8150.03%US$41,342NewJun 30, 2026
Dimensional U.S. Core Equity 2 ETF8,3410.03%US$41,788No changeJul 31, 2026
Small-Cap Index Portfolio6,8660.02%US$32,202NewJun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio6,3000.02%US$29,547NewJun 30, 2026
1290 VT Micro Cap Portfolio5,5400.02%US$25,983NewJun 30, 2026
ATM Small Cap Managed Volatility Portfolio5,4560.02%US$25,589NewJun 30, 2026
Small Cap Index Trust5,3980.02%US$25,317NewJun 30, 2026
NVIT Small Cap Index Fund5,3530.02%US$25,106NewJun 30, 2026
iShares Russell Small/Mid-Cap Index Fund4,9940.02%US$25,020NewJul 31, 2026
Fidelity Small Cap Value Index Fund4,4790.02%US$21,007NewJun 30, 2026
DWS Small Cap Index VIP3,8260.01%US$17,944NewJun 30, 2026
T. Rowe Price Small-Cap Index Fund3,6840.01%US$17,278NewJun 30, 2026
Dimensional US Core Equity 1 ETF3,4190.01%US$17,129No changeJul 31, 2026
BlackRock Small Cap Index V.I. Fund3,2610.01%US$15,294NewJun 30, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio3,2590.01%US$15,285NewJun 30, 2026
Dimensional US Sustainability Core 1 ETF2,9810.01%US$14,935No changeJul 31, 2026
Voya RussellTM Small Cap Index Portfolio2,870<0.01%US$13,460NewJun 30, 2026
SA Small Cap Index Portfolio2,861<0.01%US$14,334NewJul 31, 2026
Victory Extended Market Index Fund2,789<0.01%US$13,973+607Jul 31, 2026
CVT Russell 2000 Small Cap Index Portfolio2,217<0.01%US$10,398NewJun 30, 2026
Nationwide Small Cap Index Fund2,131<0.01%US$10,676NewJul 31, 2026
Venerable Small Cap Index Fund1,953<0.01%US$9,160NewJun 30, 2026
PD Small-Cap Growth Index Portfolio1,950<0.01%US$9,146NewJun 30, 2026
Voya VACS Index Series SC Portfolio1,839<0.01%US$8,625NewJun 30, 2026

This page holds 50 of 69 holders. Open Shareholders

Big stakes

HolderStakeSharesDate
Vivo Opportunity Fund Holdings, L.P.9.99%3.91MSep 30, 2026
Nantahala Capital Management, LLC9.99%2.81MJun 30, 2026
BVF PARTNERS L P/IL9.99%1.42MJun 30, 2025
Ra Capital Management, L.P.9.90%3.09MSep 30, 2026
BlackRock, Inc.5.30%1.41MJun 30, 2026
Great Point Partners LLC4.51%797KSep 30, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gaurav Aggarwal
Other companies: Geron Corporation (Director · Nov 26, 2023 – May 21, 2025 · Past); Sierra Oncology Inc (Director · Nov 22, 2019 – Jul 1, 2022 · Past); Ocera Therapeutics Inc (Chief Business Officer · Apr 30, 2014 – Jan 15, 2016 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – Jul 31, 2012 · Past)
Director · Since at least Mar 8, 2023
Sandeep Steve Laumas
Other companies: Instil Bio, Inc. (Chief Financial Officer & Chief Business Officer · Since at least Mar 18, 2021); BioXcel Therapeutics, Inc. (Director · Since at least Mar 7, 2018)
Director · Since at least Jul 12, 2021
John L Ryan
Other companies: Kadmon Holdings Inc (EVP, Chief Medical Officer · Jul 26, 2016 – Nov 9, 2021 · Past)
Director · Jul 12, 2021 – Sep 5, 2023 · Past
Sara Kenkare-Mitra
Other companies: Alector, Inc. (President and Head of R&D · Since at least Dec 15, 2021)
Director · Since at least Sep 5, 2023
Brigitte SchillerDirector · Jul 12, 2021 – Jul 15, 2022 · Past
Douglas JermasekEVP, Corporate Strategy · Since at least Nov 21, 2022
John TownsendCFO · Since at least Jul 12, 2021
Meredith ManningBoard Member · Since at least Oct 1, 2026
Pramod GuptaEVP, Pharmaceuticals and BD · Since at least Jul 12, 2021
Shalabh GuptaFounder, President, Chief Executive Officer, and Chairman of the Board · Since at least Jul 12, 2021

Open People

Log in to ask 6ix AI your own questions about Unicycive Therapeutics, Inc.